Healthdirect Free Australian health advice you can count on.
Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately
healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.
Emergency for Queensland, Cyclone Alfred
Health services may not be operating as usual in parts of Queensland and NSW. Check the healthdirect Service Finder for the latest information on health services in your area.
To seek advice or assistance in Queensland, call 13 Health (13 43 25 84), otherwise call healthdirect on 1800 022 222. For urgent help from police, fire or ambulance services, call triple zero (000).
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
For symptomatic control and reduction of growth hormone and IGF-l plasma levels in patients with acromegaly, including those who are inadequately controlled by surgery, radiotherapy, or dopamine agonist treatment. Octreotide treatment is also indicated in acromegalic patients unfit or unwilling to undergo surgery, or in the interim period until radiotherapy becomes fully effective.,For the relief of symptoms associated with the following functional tumours of the gastro-entero-pancreatic endocrine system:
- Carcinoid tumours with features of the carcinoid syndrome
- Vasoactive intestinal peptide secreting tumours [VIPomas]
Octreotide is not curative in these patients.,For reduction of the incidence of complications following pancreatic surgery.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
For symptomatic control and reduction of growth hormone and IGF-l plasma levels in patients with acromegaly, including those who are inadequately controlled by surgery, radiotherapy, or dopamine agonist treatment. Octreotide treatment is also indicated in acromegalic patients unfit or unwilling to undergo surgery, or in the interim period until radiotherapy becomes fully effective.,For the relief of symptoms associated with the following functional tumours of the gastro-entero-pancreatic endocrine system:
- Carcinoid tumours with features of the carcinoid syndrome
- Vasoactive intestinal peptide secreting tumours [VIPomas]
Octreotide is not curative in these patients.,For reduction of the incidence of complications following pancreatic surgery.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
For symptomatic control and reduction of growth hormone and IGF-l plasma levels in patients with acromegaly, including those who are inadequately controlled by surgery, radiotherapy, or dopamine agonist treatment. Octreotide treatment is also indicated in acromegalic patients unfit or unwilling to undergo surgery, or in the interim period until radiotherapy becomes fully effective.,For the relief of symptoms associated with the following functional tumours of the gastro-entero-pancreatic endocrine system:
- Carcinoid tumours with features of the carcinoid syndrome
- Vasoactive intestinal peptide secreting tumours [VIPomas]
Octreotide is not curative in these patients.,For reduction of the incidence of complications following pancreatic surgery.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
